BUY Aurobindo Pharma — Sandip Sabharwal
Aurobindo Pharma share price target & all analyst calls
bySandip SabharwalHorizon: NA (inferred Intraday)22 Jul 2026, 7:23 am ISTvia CNBC Awaaz.
Entry₹1,564Inferred
Stop loss₹1,560-0.26% risk
Exit₹1,56022 Jul 2026, 9:15 am
Stop-loss hit-0.26%
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting0 opposing
Supports the BUY call (1)
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aurobindo Pharma
- SELL — Sahaj Agrawal, Kotak Securities21 Oct 2026 · ~2 weeks · target ₹1,540 · Active
- BUY — Arun Kumar Mantri12 Oct 2026 · ~2 weeks · target ₹1,745 · SL hit
- BUY — Ajit Mishra, Religare12 Oct 2026 · ~2 weeks · target ₹1,820 · SL hit
- BUY — Manas Jaiswal12 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Rupak De, LKP Securities9 Oct 2026 · ~2 weeks · target ₹1,800 · SL hit
More from Sandip Sabharwal
- BUY IndusInd Bank9 Oct 2026 · ~1 year · target ₹1,100 · Active
- BUY Bajaj Finance23 Sept 2026 · ~3 months · target ₹1,070 · SL hit
- BUY Sun Pharmaceutical Industries23 Sept 2026 · ~3 months · target ₹1,920 · SL hit
- BUY Prestige Estates Projects4 Sept 2026 · ~3 months · target ₹1,750 · Active
- BUY V-Guard Industries3 Sept 2026 · ~1 year · target ₹400 · Active